Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark “Quest Laboratories Limited”. The company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. This comprehensive approach allows the Company to address a wide range of medical needs and preferences among patients.
The Company holds WHO Schedule M GMP, and GLP certifications, adhering to the stringent guidelines set by the World Health Organization. With manufacturing under one roof, the company maintains stringent quality control standards throughout the entire manufacturing process. By doing so, they ensure that their products meet the relevant quality standards before they reach the market.
The Company also possesses a Good Laboratory Practice (GLP) certificate issued by the Food & Drug Administration, Bhopal, Madhya Pradesh, indicating its commitment to maintaining high standards of quality and compliance in laboratory operations, particularly within the pharmaceutical sector. Their in-house laboratory is equipped with various equipment such as HPLC (High-Performance Liquid Chromatography), GC (Gas Chromatography), FTIR (Fourier Transform Infrared Spectroscopy), UV (Ultraviolet-Visible Spectroscopy), Dissolution apparatus, and other advanced instruments. This comprehensive suite of tools enables us to conduct a wide array of tests and analyses efficiently and accurately.
Objects of the Issue:
- Funding of capital expenditure towards purchase of plant and machinery for expansion at the existing manufacturing facility
- Funding working capital requirements of the company
- General corporate purposes.
Quest Laboratories IPO Review
- Avoid
Quest Laboratories IPO Date & Price Band Details
| IPO Open: | May 15, 2024 |
| IPO Close: | May 17, 2024 |
| IPO Size: | Approx ₹43.16 Crores, 4,449,600 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹93 to ₹97 Per Equity Share |
| IPO Listing on: | NSE SME |
| Retail Quota: | 35% of the net offer |
| QIB Quota: | 50% of the net offer |
| NII Quota: | 15% of the net offer |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors in IPO: | Click Here |
Quest Laboratories IPO Market Lot
The Quest Laboratories IPO minimum market lot is 1200 shares with a ₹116,400 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 1200 | ₹116,400 |
| Retail Maximum | 1 | 1200 | ₹116,400 |
| S-HNI Minimum | 2 | 2400 | ₹232,800 |
Quest Laboratories IPO Dates
The Quest Laboratories IPO date is May 15 and the IPO close date is May 17. The IPO allotment date is May 21 and the IPO might list on May 23.
| IPO Open Date: | May 15, 2024 |
| IPO Close Date: | May 17, 2024 |
| Basis of Allotment: | May 21, 2024 |
| Refunds: | May 22, 2024 |
| Credit to Demat Account: | May 22, 2024 |
| IPO Listing Date: | May 23, 2024 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Quest Laboratories IPO Form
How to apply Quest Laboratories IPO? You can apply Quest Laboratories IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Quest Laboratories IPO in the Invest section. The other option you can apply Quest Laboratories IPO via IPO forms download via the NSE website. Check out the Quest Laboratories forms – click NSE IPO Forms download, fill and submit in your bank or with your broker.
Quest Laboratories Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2021 | ₹30.44 | ₹29.65 | ₹0.66 |
| 2022 | ₹59.54 | ₹53.78 | ₹4.11 |
| 2023 | ₹61.87 | ₹54.91 | ₹5.03 |
| Dec 2023 | ₹62.18 | ₹51.03 | ₹7.75 |
Quest Laboratories IPO Valuation – FY2023
Check Quest Laboratories IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹4.66 per Equity Share |
| Price/Earning P/E Ratio: | NA |
| Return on Net Worth (RoNW): | 33.47% |
| Net Asset Value (NAV): | ₹13.93 per Equity Share |
Peer Group
- Beta Drugs Limited
- Alpa Laboratories Limited
- Zenith Drugs Limited
Company Promoters
- Mr. Anil Kumar Sabarwal
- Ms. Tejaswini Sabarwal
Quest Laboratories IPO Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: [email protected]
Website: http://www.bigshareonline.com
Quest Laboratories IPO Allotment Status
Check Quest Laboratories IPO allotment status on Bigshare website URL. Click Here
Quest Laboratories IPO Lead Managers aka Merchant Bankers
- Shreni Shares Limited
Company Address
Quest Laboratories Limited
Plot No. 45, Sector III
Pithampur Industrial Area, Pithampur
Dhar – 454775,
Phone: 07292292374
Email: [email protected]
Website: https://www.questlabltd.com/
